{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:26:58Z","timestamp":1770748018289,"version":"3.49.0"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2013,7,5]],"date-time":"2013-07-05T00:00:00Z","timestamp":1372982400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0068149","type":"journal-article","created":{"date-parts":[[2013,7,5]],"date-time":"2013-07-05T21:16:34Z","timestamp":1373058994000},"page":"e68149","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":45,"title":["Differences in Aqueous Concentrations of Cytokines in Macular Edema Secondary to Branch and Central Retinal Vein Occlusion"],"prefix":"10.1371","volume":"8","author":[{"given":"Jing","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanrong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,7,5]]},"reference":[{"key":"ref1","first-page":"133","article-title":"The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study","volume":"98","author":"R Klein","year":"2000","journal-title":"Trans Am Ophthalmol Soc"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ajo.2008.08.016","article-title":"Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion","volume":"147","author":"RF Spaide","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ophtha.2009.07.017","article-title":"The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia","volume":"117","author":"S Rogers","year":"2010","journal-title":"Ophthalmology"},{"key":"ref4","unstructured":"Clarkson JG (1994) Central Vein Occlusion Study: photographic protocol and early natural history. Trans Am Ophthalmol Soc 92: 203\u2013213; discussion 213\u2013205."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1001\/archopht.124.5.726","article-title":"Ten-year incidence of retinal vein occlusion in an older population: the Blue Mountains Eye Study","volume":"124","author":"S Cugati","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s11239-009-0384-5","article-title":"Retinal vein occlusion: evaluation of \u201cclassic\u201d and \u201cemerging\u201d risk factors and treatment","volume":"29","author":"M Turello","year":"2010","journal-title":"J Thromb Thrombolysis"},{"key":"ref7","first-page":"705","article-title":"Treatment of macular edema due to retinal vein occlusions","volume":"5","author":"R Channa","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archopht.1997.01100150488006","article-title":"Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group","volume":"115","journal-title":"Arch Ophthalmol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1167\/iovs.08-2510","article-title":"Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab","volume":"50","author":"M Funk","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1167\/iovs.10-6299","article-title":"Multivariate analyses of inflammatory cytokines in eyes with branch retinal vein occlusion: relationships to bevacizumab treatment","volume":"52","author":"S Kaneda","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.eye.6702498","article-title":"Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion","volume":"22","author":"H Noma","year":"2008","journal-title":"Eye (Lond)"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0002-9394(03)00228-9","article-title":"Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion","volume":"136","author":"CH Park","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s10384-011-0004-8","article-title":"Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion","volume":"55","author":"Y Suzuki","year":"2011","journal-title":"Jpn J Ophthalmol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0161-6420(83)34530-9","article-title":"Classification of central retinal vein occlusion","volume":"90","author":"SS Hayreh","year":"1983","journal-title":"Ophthalmology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0161-6420(95)30849-4","article-title":"Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report","volume":"102","journal-title":"Ophthalmology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/112067211002000125","article-title":"Bevacizumab in central retinal vein occlusion: a retrospective analysis after 2 years of treatment","volume":"20","author":"A Stahl","year":"2010","journal-title":"Eur J Ophthalmol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1097\/IAE.0b013e318219de8b","article-title":"Treatment of macular edema because of occlusive vasculitis with bevacizumab (avastin): efficacy of three consecutive monthly injections","volume":"31","author":"E Nuti","year":"2011","journal-title":"Retina"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/jop.2009.0090","article-title":"Intravitreal bevacizumab (avastin) in the treatment of macular edema associated with perfused retinal vein occlusion","volume":"26","author":"KH Hung","year":"2010","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/IAE.0b013e3181f4420d","article-title":"Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion","volume":"31","author":"X Ding","year":"2011","journal-title":"Retina"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.ajo.2011.03.033","article-title":"Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema","volume":"152","author":"HJ Sohn","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1136\/bjophthalmol-2012-301913","article-title":"Comparison of aqueous concentrations of angiogenic and inflammatory cytokines in diabetic macular oedema and macular oedema due to branch retinal vein occlusion","volume":"96","author":"WJ Lee","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1432-1327.1999.00657.x","article-title":"Serum amyloid A, the major vertebrate acute-phase reactant","volume":"265","author":"CM Uhlar","year":"1999","journal-title":"Eur J Biochem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00062752-200001000-00012","article-title":"Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states","volume":"7","author":"S Urieli-Shoval","year":"2000","journal-title":"Curr Opin Hematol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.vetimm.2005.01.004","article-title":"Serum amyloid A production by chicken fibroblast-like synoviocytes","volume":"106","author":"N Upragarin","year":"2005","journal-title":"Vet Immunol Immunopathol"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Ma Y, Tao Y, Lu Q, Jiang YR (2011) Intraocular expression of serum amyloid a and interleukin-6 in proliferative diabetic retinopathy. Am J Ophthalmol 152: 678\u2013685 e672.","DOI":"10.1016\/j.ajo.2011.03.007"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12026-011-8209-y","article-title":"Molecular interactions within the IL-6\/IL-12 cytokine\/receptor superfamily","volume":"51","author":"LL Jones","year":"2011","journal-title":"Immunol Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev-pharmtox-010611-134715","article-title":"Therapeutic targeting of the interleukin-6 receptor","volume":"52","author":"T Tanaka","year":"2012","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0165-2478(93)90078-G","article-title":"Effects of interleukin-1, -2, -4, -6, interferon-gamma and granulocyte\/macrophage colony stimulating factor on human vascular endothelial cells","volume":"35","author":"C Holzinger","year":"1993","journal-title":"Immunol Lett"},{"key":"ref29","first-page":"3974","article-title":"Mechanisms of retinal and choroidal neovascularization","volume":"35","author":"PA D\u2019Amore","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/archopht.1990.01070080113046","article-title":"Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy","volume":"108","author":"A Sivalingam","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0002-9394(14)72066-5","article-title":"Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes","volume":"122","author":"RN Frank","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1001\/archopht.120.12.1644","article-title":"Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion","volume":"120","author":"SR Boyd","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/mt.2008.10","article-title":"Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator","volume":"16","author":"PA Campochiaro","year":"2008","journal-title":"Mol Ther"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2353\/ajpath.2006.050479","article-title":"Basic fibroblast growth factor (bFGF, FGF-2) potentiates leukocyte recruitment to inflammation by enhancing endothelial adhesion molecule expression","volume":"168","author":"SI Zittermann","year":"2006","journal-title":"Am J Pathol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0068149","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T08:48:56Z","timestamp":1563353336000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0068149"}},"subtitle":[],"editor":[{"given":"Demetrios","family":"Vavvas","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,7,5]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2013,7,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0068149","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,5]]}}}